Bioactivity of an oxymatrine-based commercial formulation against Brevipalpus yothersi Baker and its effects on predatory mites in citrus groves.

ABSTRACT

The acaricidal bioactivity of an oxymatrine-based commercial formulation against Brevipalpus yothersi Baker (Acari Tenuipalpidae), a vector mite of the Citrus leprosis virus (CiLV), and its impact on predatory mites were assessed. For this purpose, laboratory and field assays using bioacaricide concentrations ranging from 0.5 to 2.0 mg L-1 of oxymatrine were performed during the years from 2015 to 2016. Laboratory results showed that the oxymatrine-based commercial formulation does not cause deleterious effects on B. yothersi eggs; however, it causes high larval mortality. For adult females, the bioacaricide caused high acute toxicity and residual effect for at least 5 days after application. In the field, the bioacaricide exhibited high acaricidal activity against B. yothersi, with efficacy levels similar to that of synthetic acaricide spirodiclofen (48 mg L-1) until 49 days after the application. The application of the bioacaricide did not negatively affect the population levels of phytoseiid predatory mites. Therefore, our results suggest that the oxymatrine-based commercial formulation is an important tool for management of the citrus leprosis mite in citrus groves.